These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12685875)

  • 1. Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
    Cabrera-Rode E; Perich P; Diaz-Horta O; Tiberti C; Molina G; Arranz C; Martin JM; Licea M; De Leiva AD; Puig-Domingo M; Dimario U
    Autoimmunity; 2002 Nov; 35(7):469-74. PubMed ID: 12685875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP
    Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes in insulin-treated adult-onset diabetic subjects.
    Willis J; Scott R; Brown L; Zimmet P; MacKay I; Rowley M
    Diabetes Res Clin Pract; 1998 Oct; 42(1):49-53. PubMed ID: 9884033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for latent autoimmune diabetes (LADA) in adults.
    Brophy S; Brunt H; Davies H; Mannan S; Williams R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis.
    da Silva ME; Porta G; Goldberg AC; Bittencourt PL; Fukui RT; Correia MR; Miura IK; Pugliese RS; Baggio VL; Cançado EL; Kalil J; Santos RF; Rochal DM; Wajchenberg BL; Ursich MJ; Rosenbloom AL
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):831-40. PubMed ID: 12099394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
    Falorni A; Calcinaro F
    Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus.
    van Deutekom AW; Heine RJ; Simsek S
    Diabet Med; 2008 Feb; 25(2):117-25. PubMed ID: 18028440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.
    Kawasaki E; Abiru N; Ide A; Sun F; Fukushima T; Takahashi R; Kuwahara H; Fujita N; Kita A; Oshima K; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
    Ann N Y Acad Sci; 2003 Nov; 1005():440-8. PubMed ID: 14679108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.